129 related articles for article (PubMed ID: 36075285)
1. Prognostic impact of Breslow thickness in acral melanoma: A retrospective analysis.
Wei X; Chen Y; Yao H; Wu D; Li H; Zhang R; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Gershenwald JE; Balch CM; Guo J; Si L
J Am Acad Dermatol; 2022 Dec; 87(6):1287-1294. PubMed ID: 36075285
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of ulceration varies across Breslow thicknesses and clinical stages in acral melanoma: a retrospective study.
Wei X; Wu D; Chen Y; Li H; Zhang R; Yao H; Chi Z; Cui C; Bai X; Mao L; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Lian B; Kong Y; Dai J; Tang B; Wang X; Guo J; Si L
Br J Dermatol; 2022 Jun; 186(6):977-987. PubMed ID: 35042273
[TBL] [Abstract][Full Text] [Related]
3. Surgical resection margin for T3-T4 primary acral melanoma: a multicenter retrospective cohort study.
Sun W; Xu Y; Qu X; Jin Y; Wang C; Yan W; Chen Y
Arch Dermatol Res; 2023 Oct; 315(8):2305-2312. PubMed ID: 36988664
[TBL] [Abstract][Full Text] [Related]
4. Clinical and pathological features of acral melanoma in a South African population: A retrospective study.
De Wet J; Tod B; Visser WI; Jordaan HF; Schneider JW
S Afr Med J; 2018 Aug; 108(9):777-781. PubMed ID: 30182904
[TBL] [Abstract][Full Text] [Related]
5. The Clinicopathological and Survival Profiles Comparison Across Primary Sites in Acral Melanoma.
Wei X; Wu D; Li H; Zhang R; Chen Y; Yao H; Chi Z; Sheng X; Cui C; Bai X; Qi Z; Li K; Lan S; Chen L; Guo R; Yao X; Mao L; Lian B; Kong Y; Dai J; Tang B; Yan X; Wang X; Li S; Zhou L; Balch CM; Si L; Guo J
Ann Surg Oncol; 2020 Sep; 27(9):3478-3485. PubMed ID: 32253677
[TBL] [Abstract][Full Text] [Related]
6. Association between Breslow thickness and dermoscopic findings in acral melanoma.
Mun JH; Jo G; Darmawan CC; Park J; Bae JM; Jin H; Kim WI; Kim HS; Ko HC; Kim BS; Kim MB
J Am Acad Dermatol; 2018 Nov; 79(5):831-835. PubMed ID: 29906546
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of tumor size for primary invasive cutaneous melanoma: A population-based study, 2004-2016.
Ma Q; Suo H; Zhu L; Qian Y; Sun X; Xie J; Li Q; Fu Y; Li J; Tao J
Cancer Med; 2020 Jul; 9(13):4561-4571. PubMed ID: 32367684
[TBL] [Abstract][Full Text] [Related]
8. Prognosis of acral melanoma: a series of 281 patients.
Bello DM; Chou JF; Panageas KS; Brady MS; Coit DG; Carvajal RD; Ariyan CE
Ann Surg Oncol; 2013 Oct; 20(11):3618-25. PubMed ID: 23838913
[TBL] [Abstract][Full Text] [Related]
9. Identification of higher risk thin melanomas should be based on Breslow depth not Clark level IV.
Owen SA; Sanders LL; Edwards LJ; Seigler HF; Tyler DS; Grichnik JM
Cancer; 2001 Mar; 91(5):983-91. PubMed ID: 11251950
[TBL] [Abstract][Full Text] [Related]
10. Sentinel Lymph Node Biopsy in Patients With Acral Melanoma: Analysis of 201 Cases From the Brazilian National Cancer Institute.
Nunes LF; Mendes GLQ; Koifman RJ
Dermatol Surg; 2019 Aug; 45(8):1026-1034. PubMed ID: 30908362
[TBL] [Abstract][Full Text] [Related]
11. Should all patients with melanoma between 1 and 2 mm Breslow thickness undergo sentinel lymph node biopsy?
Mays MP; Martin RC; Burton A; Ginter B; Edwards MJ; Reintgen DS; Ross MI; Urist MM; Stromberg AJ; McMasters KM; Scoggins CR
Cancer; 2010 Mar; 116(6):1535-44. PubMed ID: 20108306
[TBL] [Abstract][Full Text] [Related]
12. Prognostic variables in patients with thick melanomas. Analysis of 362 cases.
Aguilar-Romero E; Chávez-Hernández JD; Zepeda-Najar C; Salcedo-Hernández RA; Lino-Silva LS
Gac Med Mex; 2021; 157(2):207-211. PubMed ID: 34270542
[TBL] [Abstract][Full Text] [Related]
13. Impact of ulceration in stages I to III cutaneous melanoma as staged by the American Joint Committee on Cancer Staging System: an analysis of the German Central Malignant Melanoma Registry.
Eigentler TK; Buettner PG; Leiter U; Garbe C;
J Clin Oncol; 2004 Nov; 22(21):4376-83. PubMed ID: 15514379
[TBL] [Abstract][Full Text] [Related]
14. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
[TBL] [Abstract][Full Text] [Related]
15. Acral melanoma: a retrospective cohort from the Brazilian National Cancer Institute (INCA).
Nunes LF; Quintella Mendes GL; Koifman RJ
Melanoma Res; 2018 Oct; 28(5):458-464. PubMed ID: 30020197
[TBL] [Abstract][Full Text] [Related]
16. Is the prognosis and course of acral melanoma related to site-specific clinicopathological features?
Paolino G; Bekkenk MW; Didona D; Eibenschutz L; Richetta AG; Cantisani C; Viti G; Carbone A; Buccini P; De Simone P; Ferrari A; Scali E; Calvieri S; Silipo V; Cigna E; Viti GP; Bottoni U
Eur Rev Med Pharmacol Sci; 2016 Mar; 20(5):842-8. PubMed ID: 27010139
[TBL] [Abstract][Full Text] [Related]
17. Melanoma staging: Varying precision and terminal digit clustering in Breslow thickness data is evident in a population-based study.
Veierød MB; Page CM; Aaserud S; Bassarova A; Jacobsen KD; Helsing P; Robsahm TE
J Am Acad Dermatol; 2018 Jul; 79(1):118-125.e1. PubMed ID: 29580861
[TBL] [Abstract][Full Text] [Related]
18. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
19. Iris Melanoma Outcomes Based on the American Joint Committee on Cancer Classification (Eighth Edition) in 432 Patients.
Shields CL; Di Nicola M; Bekerman VP; Kaliki S; Alarcon C; Fulco E; Shields JA
Ophthalmology; 2018 Jun; 125(6):913-923. PubMed ID: 29342436
[TBL] [Abstract][Full Text] [Related]
20. Acral Melanoma in Chinese: A Clinicopathological and Prognostic Study of 142 cases.
Lv J; Dai B; Kong Y; Shen X; Kong J
Sci Rep; 2016 Aug; 6():31432. PubMed ID: 27545198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
